Login / Signup

A novel minimally invasive percutaneous treatment for Essex-Lopresti joint depression-type DIACFs by ligamentotaxis.

Zhiguo ChenChongyin FanJinsong ZhangChen ZhaoXin DuWei HuangWeidong NiGang Luo
Published in: BMC surgery (2022)
In the assessment of Essex-Lopresti joint depression type DIACFs, minimally invasive percutaneous treatment by ligamentotaxis has similar clinical outcomes to traditional open reduction and internal fixation through an extended lateral approach. However, the former has the advantages of shorter preoperative waiting time and hospital stay, and lower incidence of incision complications.
Keyphrases
  • minimally invasive
  • robot assisted
  • depressive symptoms
  • healthcare
  • risk factors
  • sleep quality
  • ultrasound guided
  • electronic health record